Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast

From Legacy Research | Ad

He predicted the 2020 crash a month before it happened…He predicted this year’s collapse back in January…

And now, he’s issuing a brand-new warning – along with a unique solution.

Details here.

ITOS Insider Trading (iTeos Therapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.95%

Insider Buying (Last 12 Months): $968,400.00

Insider Selling (Last 12 Months): $69,888,662.98

iTeos Therapeutics Insider Trading History Chart

iTeos Therapeutics Share Price & Price History

^$25.36

▲ +1.66 (7.00%)

As of 08/12/2022 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

Click here now!

iTeos Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/9/2022	David Hallal	Director	Sell	1,171	$19.51	$22,846.21
5/11/2022	Aaron I Davis	Director	Sell	338,000	$18.25	$6,168,500.00	2,154,058
5/9/2022	Aaron I Davis	Director	Sell	225,000	$23.40	$5,265,000.00	2,592,058
5/2/2022	Aaron I Davis	Director	Sell	100,000	$27.49	$2,749,000.00	2,817,058
4/28/2022	Aaron I Davis	Director	Sell	150,000	$27.40	$4,110,000.00	3,042,058
4/18/2022	Michel Detheux	CEO	Sell	11,500	$31.87	$366,505.00	26,263
3/22/2022	Aaron I Davis	Director	Buy	30,000	$32.28	$968,400.00
3/22/2022	Michel Detheux	CEO	Sell	18,437	$34.17	$629,992.29
3/17/2022	Boxer Capital, Llc	Major Shareholder	Sell	575,201	$35.25	$20,275,835.25
3/11/2022	Joanne Jenkins Lager	Insider	Sell	3,500	$36.01	$126,035.00
3/1/2022	Yvonne McGrath	Insider	Sell	10,000	$36.76	$367,600.00
2/23/2022	Michel Detheux	CEO	Sell	14,500	$34.34	$497,930.00
2/11/2022	Joanne Jenkins Lager	Insider	Sell	3,500	$35.85	$125,475.00
1/25/2022	Michel Detheux	CEO	Sell	14,500	$35.68	$517,360.00
1/14/2022	Joanne Jenkins Lager	Insider	Sell	3,500	$39.32	$137,620.00
1/4/2022	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	128,550	$42.66	$5,483,943.00
1/3/2022	Detlev Biniszkiewicz	Director	Sell	3,500	$51.90	$181,650.00
1/3/2022	Joanne Jenkins Lager	Insider	Sell	7,000	$51.90	$363,300.00
12/27/2021	Matthew Gall	CFO	Sell	5,000	$46.45	$232,250.00
12/22/2021	Michel Detheux	CEO	Sell	16,163	$45.03	$727,819.89
12/20/2021	David Hallal	Director	Sell	50,000	$43.57	$2,178,500.00
12/20/2021	Michel Detheux	CEO	Sell	9,111	$43.94	$400,337.34
12/17/2021	Joanne Jenkins Lager	Insider	Sell	7,000	$41.00	$287,000.00
12/10/2021	Joanne Jenkins Lager	Insider	Sell	3,500	$34.50	$120,750.00
12/6/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	10,208	$32.59	$332,678.72
12/3/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	20,167	$34.79	$701,609.93
12/1/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	12,395	$34.28	$424,900.60
11/29/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	10,371	$34.49	$357,695.79
11/26/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	12,674	$35.75	$453,095.50
11/24/2021	Ansbert Gadicke	Major Shareholder	Sell	60,808	$36.29	$2,206,722.32
11/23/2021	Michel Detheux	CEO	Sell	14,500	$36.08	$523,160.00
11/22/2021	Ansbert Gadicke	Major Shareholder	Sell	35,333	$37.52	$1,325,694.16
11/18/2021	Joanne Jenkins Lager	Insider	Sell	28,000	$34.50	$966,000.00
11/3/2021	Michel Detheux	CEO	Sell	6,085	$28.89	$175,795.65
11/1/2021	Michel Detheux	CEO	Sell	81	$28.00	$2,268.00
10/21/2021	Michel Detheux	CEO	Sell	196	$28.00	$5,488.00
10/19/2021	Michel Detheux	CEO	Sell	201	$28.00	$5,628.00
10/18/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	6,167	$27.14	$167,372.38
10/15/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	10,932	$27.62	$301,941.84
10/15/2021	Michel Detheux	CEO	Sell	1,635	$28.01	$45,796.35
10/13/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	20,929	$27.13	$567,803.77
10/11/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	48,812	$27.24	$1,329,638.88
10/7/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	1,149	$27.00	$31,023.00
10/4/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	20,711	$27.06	$560,439.66
9/30/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	2,292	$27.00	$61,884.00
9/27/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	11,625	$27.09	$314,921.25
9/24/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	4,913	$27.81	$136,630.53
9/23/2021	Michel Detheux	CEO	Sell	5,322	$28.16	$149,867.52
9/22/2021	Bioventures 2018 L.P. Mpm	Major Shareholder	Sell	14,294	$27.54	$393,656.76
9/20/2021	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	24,303	$27.49	$668,089.47
9/17/2021	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	45,698	$28.82	$1,317,016.36
9/15/2021	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	24,104	$27.80	$670,091.20
9/13/2021	Ansbert Gadicke	Major Shareholder	Sell	35,785	$27.64	$989,097.40
9/9/2021	Ansbert Gadicke	Major Shareholder	Sell	38,028	$28.97	$1,101,671.16
9/7/2021	Ansbert Gadicke	Major Shareholder	Sell	50,996	$29.18	$1,488,063.28
9/1/2021	Michel Detheux	CEO	Sell	8,684	$28.30	$245,757.20
8/30/2021	Michel Detheux	CEO	Sell	2,322	$28.01	$65,039.22	132,104
8/27/2021	Michel Detheux	CEO	Sell	8,248	$28.17	$232,346.16
8/25/2021	Michel Detheux	CEO	Sell	861	$28.00	$24,108.00
8/23/2021	Michel Detheux	CEO	Sell	7,499	$28.06	$210,421.94	141,438
6/16/2021	Matthew Gall	CFO	Buy	5,000	$26.09	$130,450.00	5,000
6/14/2021	Michel Detheux	CEO	Sell	29,000	$28.50	$826,500.00	152,874
6/8/2021	Yvonne McGrath	VP	Sell	7,927	$20.00	$158,540.00	7,927
5/24/2021	Yvonne McGrath	VP	Sell	7,927	$21.92	$173,759.84	7,927
4/9/2021	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	119	$29.99	$3,568.81
4/7/2021	Bioventures 2014 L.P. Mpm	Major Shareholder	Sell	5,783	$32.55	$188,236.65

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for iTeos Therapeutics (NASDAQ:ITOS)

94.71% of iTeos Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

iTeos Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/13/2022	Massachusetts Financial Services Co. MA	122,346	$2.52M	0.0%	+138.1%	0.344%
8/13/2022	Quantbot Technologies LP	3,374	$69K	0.0%	N/A	0.009%
8/13/2022	Renaissance Technologies LLC	332,300	$6.85M	0.0%	+147.6%	0.935%
8/13/2022	American International Group Inc.	12,507	$0.26M	0.0%	+8.2%	0.035%
8/12/2022	Northern Trust Corp	233,285	$4.81M	0.0%	+17.9%	0.656%
8/12/2022	Virtus ETF Advisers LLC	5,790	$0.12M	0.0%	+39.1%	0.016%
8/12/2022	Credit Suisse AG	9,190	$0.19M	0.0%	-10.8%	0.026%
8/12/2022	ClariVest Asset Management LLC	19,000	$0.39M	0.0%	N/A	0.053%
8/12/2022	Rafferty Asset Management LLC	99,368	$2.05M	0.0%	+2.1%	0.280%
8/12/2022	FMR LLC	431,196	$8.88M	0.0%	-29.7%	1.213%
8/12/2022	Rhumbline Advisers	50,391	$1.04M	0.0%	+16.2%	0.142%
8/11/2022	Trexquant Investment LP	24,738	$0.51M	0.0%	+66.9%	0.070%
8/11/2022	Deutsche Bank AG	599,831	$12.36M	0.0%	-12.2%	1.688%
8/11/2022	UBS Group AG	158,204	$3.26M	0.0%	-7.3%	0.445%
8/11/2022	Alps Advisors Inc.	21,080	$0.43M	0.0%	N/A	0.059%
8/11/2022	JPMorgan Chase & Co.	559,299	$11.52M	0.0%	+146.7%	1.574%
8/10/2022	Mutual of America Capital Management LLC	3,402	$70K	0.0%	+17.4%	0.010%
8/10/2022	Principal Financial Group Inc.	167,750	$3.46M	0.0%	+22.7%	0.472%
8/10/2022	WINTON GROUP Ltd	52,264	$1.08M	0.1%	+359.2%	0.147%
8/9/2022	Swiss National Bank	45,800	$0.94M	0.0%	+37.1%	0.129%
8/9/2022	Lazard Asset Management LLC	6,887	$0.14M	0.0%	+79.5%	0.019%
8/8/2022	Texas Permanent School Fund	14,642	$0.30M	0.0%	+2.7%	0.041%
8/5/2022	Los Angeles Capital Management LLC	124,797	$2.57M	0.0%	+282.8%	0.351%
8/3/2022	Integral Health Asset Management LLC	156,553	$3.23M	0.7%	+84.2%	0.440%
8/3/2022	Candriam S.C.A.	787,651	$16.23M	0.1%	+15.2%	2.216%
8/1/2022	New York State Teachers Retirement System	21,317	$0.44M	0.0%	+249.5%	0.060%
8/1/2022	Victory Capital Management Inc.	55,111	$1.14M	0.0%	+23.8%	0.155%
8/1/2022	Yousif Capital Management LLC	19,579	$0.40M	0.0%	+3.8%	0.055%
7/29/2022	Tekla Capital Management LLC	21,181	$0.44M	0.0%	-50.0%	0.060%
7/29/2022	SG Americas Securities LLC	61,193	$1.26M	0.0%	+2.0%	0.172%
7/29/2022	Russell Investments Group Ltd.	40,400	$0.83M	0.0%	+140.5%	0.114%
7/26/2022	KBC Group NV	1,773	$37K	0.0%	N/A	0.005%
7/25/2022	Allspring Global Investments Holdings LLC	272,338	$5.61M	0.0%	+56.6%	0.766%
7/25/2022	Oregon Public Employees Retirement Fund	6,649	$0.14M	0.0%	-11.9%	0.019%
7/25/2022	Strs Ohio	30,900	$0.64M	0.0%	+41.1%	0.087%
7/21/2022	Ziegler Capital Management LLC	27,465	$0.57M	0.0%	N/A	0.077%
7/20/2022	Exchange Traded Concepts LLC	21,878	$0.45M	0.0%	+3.6%	0.062%
7/8/2022	State of Alaska Department of Revenue	15,320	$0.32M	0.0%	+9.5%	0.043%
6/30/2022	Amalgamated Bank	8,953	$0.29M	0.0%	N/A	0.025%
6/7/2022	Teachers Retirement System of The State of Kentucky	5,700	$0.18M	0.0%	N/A	0.016%
6/7/2022	Bank of America Corp DE	139,579	$4.49M	0.0%	+56.7%	0.393%
5/27/2022	Walleye Capital LLC	68,891	$2.22M	0.0%	+101.1%	0.194%
5/17/2022	Walleye Capital LLC	68,891	$2.22M	0.0%	+101.1%	0.194%
5/17/2022	Jane Street Group LLC	8,884	$0.29M	0.0%	-40.2%	0.025%
5/17/2022	Point72 Hong Kong Ltd	2,095	$67K	0.0%	N/A	0.006%
5/17/2022	Royal Bank of Canada	1,246	$40K	0.0%	-63.5%	0.004%
5/17/2022	RTW Investments LP	489,014	$15.74M	0.3%	-79.2%	1.376%
5/17/2022	Delphia USA Inc.	7,503	$0.24M	0.2%	-29.4%	0.021%
5/17/2022	Dynamic Technology Lab Private Ltd	17,100	$0.55M	0.1%	N/A	0.048%
5/17/2022	Ensign Peak Advisors Inc	2,280	$73K	0.0%	N/A	0.006%
5/17/2022	First Republic Investment Management Inc.	20,825	$0.67M	0.0%	-11.8%	0.059%
5/16/2022	California State Teachers Retirement System	20,739	$0.67M	0.0%	-9.0%	0.058%
5/16/2022	Goldman Sachs Group Inc.	183,141	$5.89M	0.0%	+56.1%	0.516%
5/16/2022	Wellington Management Group LLP	104,675	$3.37M	0.0%	-2.0%	0.295%
5/16/2022	State Street Corp	1,711,891	$55.09M	0.0%	+124.3%	4.820%
5/16/2022	Vident Investment Advisory LLC	28,983	$0.93M	0.0%	+20.0%	0.082%
5/16/2022	Invesco Ltd.	125,023	$4.02M	0.0%	+166.2%	0.352%
5/16/2022	UBS Group AG	170,690	$5.49M	0.0%	+352.1%	0.481%
5/13/2022	Silverarc Capital Management LLC	138,843	$4.47M	1.8%	+0.6%	0.391%
5/13/2022	Renaissance Technologies LLC	134,200	$4.32M	0.0%	+305.4%	0.378%
5/13/2022	Northern Trust Corp	197,884	$6.37M	0.0%	+6.6%	0.557%
5/13/2022	Charles Schwab Investment Management Inc.	145,749	$4.69M	0.0%	+2.2%	0.410%
5/13/2022	Quantedge Capital Pte Ltd	7,300	$0.24M	0.1%	N/A	0.021%
5/13/2022	Parkwood LLC	17,136	$0.55M	0.1%	N/A	0.048%
5/13/2022	First Trust Advisors LP	25,611	$0.82M	0.0%	N/A	0.072%
5/13/2022	Prudential Financial Inc.	166,621	$5.36M	0.0%	+194.2%	0.469%
5/13/2022	Federated Hermes Inc.	219,272	$7.06M	0.0%	+128.9%	0.617%
5/13/2022	American International Group Inc.	11,563	$0.37M	0.0%	+7.7%	0.033%
5/13/2022	Candriam Luxembourg S.C.A.	683,812	$22M	0.1%	-9.7%	1.926%
5/13/2022	Vanguard Group Inc.	1,476,042	$47.50M	0.0%	+39.1%	4.157%
5/13/2022	Sei Investments Co.	48,938	$1.58M	0.0%	+174.6%	0.138%
5/12/2022	Integral Health Asset Management LLC	85,000	$2.74M	0.7%	+70.0%	0.239%
5/12/2022	Yousif Capital Management LLC	18,864	$0.61M	0.0%	N/A	0.053%
5/12/2022	Great West Life Assurance Co. Can	17,012	$0.56M	0.0%	+2,067.1%	0.048%
5/12/2022	BlackRock Inc.	3,331,313	$107.20M	0.0%	+106.5%	9.380%
5/12/2022	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	17,333	$0.56M	0.0%	N/A	0.049%
5/12/2022	Rhumbline Advisers	43,373	$1.40M	0.0%	+59.0%	0.122%
5/12/2022	Metropolitan Life Insurance Co NY	1,365	$44K	0.0%	-77.4%	0.004%
5/12/2022	MetLife Investment Management LLC	12,678	$0.41M	0.0%	+58.5%	0.036%
5/12/2022	Artal Group S.A.	400,000	$12.87M	0.5%	-26.5%	1.126%
5/12/2022	Acadian Asset Management LLC	126,199	$4.06M	0.0%	+1,583.3%	0.355%
5/12/2022	Citigroup Inc.	32,353	$1.04M	0.0%	-84.5%	0.091%
5/11/2022	American Century Companies Inc.	121,395	$3.91M	0.0%	+151.8%	0.342%
5/11/2022	Bank of New York Mellon Corp	186,800	$6.01M	0.0%	+82.0%	0.526%
5/11/2022	Massachusetts Financial Services Co. MA	51,387	$1.65M	0.0%	+107.0%	0.145%
5/11/2022	State of Tennessee Treasury Department	13,367	$0.43M	0.0%	N/A	0.038%
5/11/2022	JPMorgan Chase & Co.	226,674	$7.30M	0.0%	+286.3%	0.638%
5/11/2022	WINTON GROUP Ltd	11,381	$0.37M	0.0%	N/A	0.032%
5/10/2022	Sectoral Asset Management Inc.	234,150	$7.54M	1.3%	+192.7%	0.659%
5/10/2022	ProShare Advisors LLC	8,138	$0.26M	0.0%	-13.3%	0.023%
5/10/2022	CNA Financial Corp	10,055	$0.32M	0.1%	-20.0%	0.028%
5/9/2022	Principal Financial Group Inc.	136,746	$4.40M	0.0%	N/A	0.385%
5/9/2022	Swiss National Bank	33,400	$1.08M	0.0%	+7.7%	0.094%
5/6/2022	Los Angeles Capital Management LLC	32,605	$1.05M	0.0%	N/A	0.092%
5/6/2022	State Board of Administration of Florida Retirement System	30,220	$0.97M	0.0%	N/A	0.085%
5/6/2022	Texas Permanent School Fund	14,254	$0.46M	0.0%	N/A	0.040%
5/5/2022	Russell Investments Group Ltd.	16,800	$0.54M	0.0%	+281.8%	0.047%
5/4/2022	Victory Capital Management Inc.	44,520	$1.20M	0.0%	N/A	0.125%
5/3/2022	Jackson Creek Investment Advisors LLC	25,572	$0.82M	0.3%	-32.7%	0.072%
5/2/2022	Mutual of America Capital Management LLC	2,897	$93K	0.0%	N/A	0.008%

Data available starting January 2016

Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2 clinical trial, as well as used to engage the Fc gamma receptor, or Fc?R to activate dendritic cells and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts.

Today's Range

Now: $25.36

$23.59

$26.12

50 Day Range

MA: $22.73

$17.27

$27.25

52 Week Range

Now: $25.36

$16.21

$52.43

Volume

470,717 shs

Average Volume

334,998 shs

Market Capitalization

$902.31 million

P/E Ratio

2.91

Dividend Yield

N/A

Beta

1.5

Who are the company insiders with the largest holdings of iTeos Therapeutics?: iTeos Therapeutics' top insider shareholders include:
Aaron I Davis (Director)
Michel Detheux (CEO)
Yvonne Mcgrath (VP)
Matthew Gall (CFO)
Ansbert Gadicke (Major Shareholder)
Bioventures 2014 LP Mpm (Major Shareholder)
Bioventures 2018 LP Mpm (Major Shareholder)
Boxer Capital, Llc (Major Shareholder)
David Hallal (Director)
Detlev Biniszkiewicz (Director)
Joanne Jenkins Lager (Insider)
Les B Korsh (VP)
Yvonne Mcgrath (Insider)
Learn More about top insider investors at iTeos Therapeutics.
Who are the major institutional investors of iTeos Therapeutics?: iTeos Therapeutics' top institutional shareholders include:
Candriam S.C.A. — 2.22%
Deutsche Bank AG — 1.69%
JPMorgan Chase & Co. — 1.57%
FMR LLC — 1.21%
Renaissance Technologies LLC — 0.93%
Allspring Global Investments Holdings LLC — 0.77%
Learn More about top institutional investors of iTeos Therapeutics stock.
Which institutional investors are selling iTeos Therapeutics stock?: Within the last quarter, ITOS stock was sold by these institutional investors:
FMR LLC
Deutsche Bank AG
Tekla Capital Management LLC
UBS Group AG
Credit Suisse AG
Oregon Public Employees Retirement Fund
During the previous year, company insiders that have sold iTeos Therapeutics company stock include:
Aaron I Davis (Director)
Michel Detheux (CEO)
Yvonne Mcgrath (VP)
Matthew Gall (CFO)
Ansbert Gadicke (Major Shareholder)
Bioventures 2014 LP Mpm (Major Shareholder)
Bioventures 2018 LP Mpm (Major Shareholder)
Boxer Capital, Llc (Major Shareholder)
David Hallal (Director)
Detlev Biniszkiewicz (Director)
Joanne Jenkins Lager (Insider)
Learn More investors selling iTeos Therapeutics stock.
Which institutional investors are buying iTeos Therapeutics stock?: Within the last quarter, ITOS stock was acquired by institutional investors including:
JPMorgan Chase & Co.
Renaissance Technologies LLC
Candriam S.C.A.
Allspring Global Investments Holdings LLC
Los Angeles Capital Management LLC
Integral Health Asset Management LLC
Massachusetts Financial Services Co. MA
WINTON GROUP Ltd
During the last year, these company insiders have bought iTeos Therapeutics stock:
Aaron I Davis (Director)
Michel Detheux (CEO)
Learn More investors buying iTeos Therapeutics stock.

27 U.S. Cities Where Stocks Yield 26% a Year

From Investing Daily | Ad

What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.

Get in on the action here.